Free Trial

Cumberland Pharmaceuticals (CPIX) SEC Filings & 10K Form

Cumberland Pharmaceuticals logo
$2.27 -0.05 (-2.16%)
(As of 12/20/2024 05:31 PM ET)

Recent Cumberland Pharmaceuticals SEC Filings

DateFilerForm TypeView
12/09/2024
4:04 PM
Cumberland Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/05/2024
4:02 PM
Cumberland Pharmaceuticals (Issuer)
Krogulski Kenneth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
4:03 PM
Cumberland Pharmaceuticals (Issuer)
KAZIMI A J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
4:04 PM
Cumberland Pharmaceuticals (Issuer)
Jones James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
4:05 PM
Cumberland Pharmaceuticals (Issuer)
Young Caroline (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2024
4:04 PM
Cumberland Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2024
4:09 PM
Cumberland Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2024
4:12 PM
Cumberland Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2024
3:38 PM
Cumberland Pharmaceuticals (Issuer)
Krogulski Kenneth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
3:39 PM
Cumberland Pharmaceuticals (Issuer)
KAZIMI A J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
3:39 PM
Cumberland Pharmaceuticals (Issuer)
Jones James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2024
4:15 PM
Cumberland Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2024
3:06 PM
Cumberland Pharmaceuticals (Issuer)
Krogulski Kenneth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
3:07 PM
Cumberland Pharmaceuticals (Issuer)
KAZIMI A J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
3:08 PM
Cumberland Pharmaceuticals (Issuer)
Jones James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
10:31 AM
Cumberland Pharmaceuticals (Issuer)
Young Caroline (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
9:42 AM
Cumberland Pharmaceuticals (Issuer)
Young Caroline (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
5:29 PM
Cumberland Pharmaceuticals (Issuer)
Krogulski Kenneth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
4:40 PM
Cumberland Pharmaceuticals (Issuer)
KAZIMI A J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
4:42 PM
Cumberland Pharmaceuticals (Issuer)
Jones James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
4:07 PM
Cumberland Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/02/2024
4:33 PM
Cumberland Pharmaceuticals (Issuer)
Young Caroline (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
4:31 PM
Cumberland Pharmaceuticals (Issuer)
KAZIMI A J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
4:32 PM
Cumberland Pharmaceuticals (Issuer)
Jones James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
4:32 PM
Cumberland Pharmaceuticals (Issuer)
Krogulski Kenneth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2024
3:37 PM
Cumberland Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2024
4:14 PM
Cumberland Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/26/2024
7:22 PM
Cumberland Pharmaceuticals (Issuer)
Hamm John M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2024
7:24 PM
Anthony Todd M. (Reporting)
Cumberland Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2024
7:25 PM
Bitterman Chris T. (Reporting)
Cumberland Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2024
7:26 PM
Cumberland Pharmaceuticals (Issuer)
Herman James L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2024
7:28 PM
Cumberland Pharmaceuticals (Issuer)
KAZIMI A J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2024
7:29 PM
Brown Martin S JR (Reporting)
Cumberland Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2024
7:31 PM
Cumberland Pharmaceuticals (Issuer)
Young Caroline (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2024
7:31 PM
Cumberland Pharmaceuticals (Issuer)
Galante Joseph C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2024
7:32 PM
Cumberland Pharmaceuticals (Issuer)
Jones James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2024
7:33 PM
Cumberland Pharmaceuticals (Issuer)
Krogulski Kenneth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
4:15 PM
Cumberland Pharmaceuticals (Filer)
Form 424B5
03/20/2024
4:20 PM
Cumberland Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2024
4:03 PM
Cumberland Pharmaceuticals (Filer)
Form DEF 14A
03/13/2024
4:04 PM
Cumberland Pharmaceuticals (Filer)
Form DEFA14A
This Indicator called BOTH NVDA rallies (Ad)

Rarely would I label something as “the best” But in this rare instance, I believe this is THE BEST indicator for trading Nvida’s stock. Except, it’s not another tech stock like Nvidia. But rather a stock hiding in broad daylight… So, if you’d like to see what this stock is…

03/05/2024
4:10 PM
Cumberland Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/09/2024
4:27 PM
Cumberland Pharmaceuticals (Subject)
Form SC 13G
12/28/2023
4:07 PM
Cumberland Pharmaceuticals (Issuer)
KAZIMI A J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2023
4:08 PM
Cumberland Pharmaceuticals (Issuer)
Krogulski Kenneth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2023
4:10 PM
Cumberland Pharmaceuticals (Issuer)
Young Caroline (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2023
4:11 PM
Cumberland Pharmaceuticals (Issuer)
Jones James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2023
11:15 PM
Cumberland Pharmaceuticals (Filer)
Form EFFECT
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CPIX) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners